GleamWall
中文EN

KNSA Kiniksa Pharmaceuticals International, plc

Pharmaceutical Preparations · Nasdaq · SEC CIK 1730430 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY58.2%
TTM net income YoY205.1%
TTM EPS YoY193.3%
Revenue 3-yr CAGR56.1%
Net income 3-yr CAGR—

Margins

Gross margin90.2%
Operating margin13.8%
Net margin11.6%
FCF margin20.8%
EBITDA margin13.9%

Returns

ROE17.6%
ROA12.9%
ROIC (approx.)19.8%
Asset turnover1.12x

Leverage & solvency

Liabilities / assets27.8%
Debt / equity0.00x
Current ratio3.91x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.81x
Accruals ratio-10.5%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$677.56M$423.24M
Cost of revenue$77.67M$60.91M
Gross profit$599.89M$362.33M
R&D expense$96.85M$111.62M
SG&A expense$196.27M$168.01M
Operating income$77.22M-$45.62M
Pretax income$88.87M-$36.15M
Income tax$29.86M$7.04M
Net income$59.01M-$43.19M
EBITDA$78.78M-$43.92M
EPS (basic)0.80-0.60
EPS (diluted)0.75-0.60
Weighted avg. shares (diluted)78.98M71.42M
Balance sheet
Cash & equivalents$165.60M$183.58M
Short-term investments$248.48M$60.05M
Receivables$15.59M$41.72M
Inventory$54.90M$26.36M
Current assets$527.18M$331.80M
PP&E, net$1.94M$662,000
Intangibles$15.25M$16.25M
Total assets$763.63M$580.55M
Current liabilities$139.18M$100.62M
Total liabilities$196.03M$142.12M
Shareholders' equity$567.61M$438.44M
Cash flow statement
Operating cash flow$137.99M$25.69M
Capital expenditure$1.57M$277,000
Free cash flow$136.42M$25.41M
Investing cash flow-$188.99M$37.67M
Financing cash flow$33.02M$12.27M
Depreciation & amortization$1.55M$1.70M
Stock-based compensation$37.00M$30.69M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.